Australia Biotechnology Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Australia Biotechnology Market Overview

Biotechnology plays a pivotal role in advancing medical, agricultural, and industrial solutions by leveraging innovative biological processes to improve human health, enhance productivity, and support sustainable development. The market demonstrates strong growth driven by expanding research capabilities, rising healthcare demands, and increasing governmental support for advanced therapeutics and life-science innovation. The market was valued at USD 36.17 Billion in 2025, reflecting the sector’s accelerating progress and its strategic importance in strengthening national healthcare outcomes, fostering scientific excellence, and promoting the commercialization of cutting-edge biotechnological applications across diverse industries.

Australia Biotechnology Market Growth Driver

Advancements in Biosimilar Access to Boost the Market Expansion

The rising adoption of advanced biosimilars that improve therapeutic accessibility and support cost-efficient care is a significant factor driving the growth in the market. In July 2025, Biocon Biologics introduced Nepexto®, a biosimilar to Enbrel® (Etanercept), in Australia through its partner Generic Health. This launch underscores growing confidence in biosimilar therapies for autoimmune conditions and aligns with the nation’s increasing focus on expanding high-quality biologic alternatives. As leading global biotechnology firms broaden their immunology portfolios in Australia, the market is well-positioned for sustained expansion supported by enhanced treatment availability and improved patient outcomes.

Australia Biotechnology Market Trends

Key trends in the market include an increasing focus on next-generation biosensing technologies and a growing emphasis on advanced RNA manufacturing.

Rising Focus on Next-Generation Biosensing Technologies Likely to Enhance Market Value

The market is increasingly driven by the rapid advancement of next-generation biosensing technologies aimed at improving real-time diagnostics and biological threat detection. For instance, in August 2025, the Australian Research Council supported the launch of the ARC Research Hub for Molecular Biosensors at Point-of-Use (MOBIUS) at La Trobe University. The initiative, backed by leading institutions such as CSIRO, highlights the sector’s shift toward portable, accurate, and scalable diagnostic solutions. This growing emphasis on advanced biosensors is expected to strengthen innovation capabilities and accelerate the market’s future expansion.

Growing Focus on Advanced RNA Manufacturing Is Poised to Elevate the Australia Biotechnology Market

The increasing focus on expanding advanced RNA manufacturing capabilities, driven by increasing demand for next-generation RNA-based therapies, is a significant trend shaping the market. In September 2024, this trend was exemplified by the launch of Aurora Biosynthetics in Sydney, formed through a strategic collaboration among the New South Wales Government, RNA Australia, and Myeloid Therapeutics. The company’s integrated GMP solutions for plasmid DNA, mRNA, and lipid nanoparticles strengthen Australia’s technical capacity and reinforce its position in the Asia-Pacific RNA landscape. This ongoing shift toward specialized RNA manufacturing is expected to accelerate growth in the biotechnology market.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Australia Biotechnology Market Share

DNA Sequencing Expected to Lead the Market Share by Technology

The technology segment includes Nanobiotechnology, polymerase chain reaction technology, DNA sequencing, chromatography, tissue engineering and regeneration, cell-based assays, fermentation, and other emerging techniques. Among these, DNA sequencing is expected to lead, supported by its previously significant 15% share in the historical period. Its momentum is driven by expanding use in precision medicine, increasing demand for genomic profiling, and continuous improvements in sequencing accuracy and affordability. These advancements are likely to further strengthen its position in the coming years.

Leading Players in the Australia Biotechnology Market

Other key players in the market include Biogen Inc., Pfizer, Inc., Amgen Inc., Novo Nordisk A/S, Merck KGaA, and Johnson & Johnson Innovative Medicine.

Australia Biotechnology Market Segmentation

Key Questions Answered in the Australia Biotechnology Market Report

• What was the Australia biotechnology market value in 2025?
• What is the Australia biotechnology market forecast outlook for 2026-2035?
• What are the major factors aiding the Australia biotechnology market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major Australia biotechnology market trends?
• Which technology is expected to dominate the market segment?
• Which application is projected to lead the market segment?
• Who are the key players involved in the Australia biotechnology market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?